184 related articles for article (PubMed ID: 32680839)
1. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
[TBL] [Abstract][Full Text] [Related]
2. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.
Esmaeli B; Ahmadi MA; Youssef A; Diba R; Amato M; Myers JN; Kies M; El-Naggar A
Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):22-6. PubMed ID: 14752305
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland.
Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL
Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459
[TBL] [Abstract][Full Text] [Related]
5. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
Yang J; Zhou C; Wang Y; Fan X; Jia R
BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
[TBL] [Abstract][Full Text] [Related]
6. Current treatment of lacrimal gland carcinoma.
Woo KI; Kim YD; Sa HS; Esmaeli B
Curr Opin Ophthalmol; 2016 Sep; 27(5):449-56. PubMed ID: 27273588
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes of Eye-Sparing Surgery for Adenoid Cystic Carcinoma of Lacrimal Gland.
Han J; Kim YD; Woo KI; Sobti D
Ophthalmic Plast Reconstr Surg; 2018; 34(1):74-78. PubMed ID: 28221296
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
Tse DT; Kossler AL; Feuer WJ; Benedetto PW
Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy.
Lin YH; Huang SM; Yap WK; Yang JW; Yeung L; Tsan DL; Chang JT; Chen LC
Radiat Oncol; 2020 Jun; 15(1):156. PubMed ID: 32571366
[TBL] [Abstract][Full Text] [Related]
13. Adenoid cystic carcinoma of the lacrimal gland: is there a cure...yet?
Bartley GB; Harris GJ
Ophthalmic Plast Reconstr Surg; 2002 Sep; 18(5):315-8. PubMed ID: 12352816
[No Abstract] [Full Text] [Related]
14. Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experience.
Skinner HD; Garden AS; Rosenthal DI; Ang KK; Morrison WH; Esmaeli B; Pinnix CC; Frank SJ
Cancer; 2011 Jun; 117(12):2801-10. PubMed ID: 21656758
[TBL] [Abstract][Full Text] [Related]
15. Lacrimal gland tumor outcomes.
Aristodemou P
Ophthalmology; 2010 Jan; 117(1):196. PubMed ID: 20114119
[No Abstract] [Full Text] [Related]
16. Does Multimodal Treatment Improve Eye and Life Salvage in Adenoid Cystic Carcinoma of the Lacrimal Gland?
Manjandavida FP; Honavar SG; Murthy R; Das S; Vemuganti GK; Mulay K; Reddy VAP
Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):348-354. PubMed ID: 34873122
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT
Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
[TBL] [Abstract][Full Text] [Related]
18. Management of Lacrimal Gland Carcinoma: Lessons From the Literature in the Past 40 Years.
Woo KI; Yeom A; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2016; 32(1):1-10. PubMed ID: 26291539
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
Tse DT; Benedetto PW; Tse BC; Feuer WJ
Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
[TBL] [Abstract][Full Text] [Related]
20. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.
Friedrich RE; Bleckmann V
Anticancer Res; 2003; 23(2A):931-40. PubMed ID: 12820326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
